Clopidogrel is an antiplatelet agent that reduces the risk of myocardial infarction and stroke in patients with acute coronary syndromes and in patients with atherosclerotic vascular disease. Clopidogrel is also indicated in combination with aspirin in patients undergoing percutaneous coronary intervention (PCI), e.g. stent placement.